Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Operating Margin (2022 - 2025)

Historic Operating Margin for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 158.56%.

  • bioAffinity Technologies' Operating Margin fell 745800.0% to 158.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 153.2%, marking a year-over-year decrease of 640700.0%. This contributed to the annual value of 95.64% for FY2024, which is 2192000.0% up from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Operating Margin is 158.56%, which was down 745800.0% from 198.16% recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Operating Margin ranged from a high of 80.84% in Q1 2024 and a low of 169160.69% during Q1 2023
  • In the last 4 years, bioAffinity Technologies' Operating Margin had a median value of 178.36% in 2025 and averaged 27600.56%.
  • Its Operating Margin has fluctuated over the past 5 years, first surged by 1690798600bps in 2024, then crashed by -1110800bps in 2025.
  • bioAffinity Technologies' Operating Margin (Quarter) stood at 69213.17% in 2022, then soared by 100bps to 105.83% in 2023, then dropped by -26bps to 133.47% in 2024, then fell by -19bps to 158.56% in 2025.
  • Its last three reported values are 158.56% in Q3 2025, 198.16% for Q2 2025, and 141.73% during Q1 2025.